Harm Hermsen

Harm Hermsen

Company: UniQure

Job title: Vice President, Global Regulatory Affairs


Case Study: Successful Strategies From a Late Clinical Stage Gene Therapy Product 9:30 am

How safety and efficacy were successfully demonstrated to the regulators after modifying the gene therapy product The reasons behind selection of particular clinical trial endpoints How challenges in meeting regulatory CMC challenges are being navigatedRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.